Zimmer Biomet Holdings (ZBH) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 16.91% |
| 10 | Zimmer Biomet Holdings | 19.34 Bn | 18.93 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.24% |
| Mar 31, 2026 | 37.21% |
| Dec 31, 2025 | 287.18% |
| Sep 30, 2025 | -20.18% |
| Jun 30, 2025 | -51.55% |
| Mar 31, 2025 | -36.59% |
| Dec 31, 2024 | -38.51% |
| Sep 30, 2024 | -12.18% |
| Jun 30, 2024 | 12.39% |
| Mar 31, 2024 | -15.79% |
| Dec 31, 2023 | 1,891.33% |
| Sep 30, 2023 | 33.54% |
| Jun 30, 2023 | 42.45% |
| Mar 31, 2023 | 100.40% |
| Dec 31, 2022 | -125.05% |
| Sep 30, 2022 | 19.73% |
| Jun 30, 2022 | 58.38% |
| Mar 31, 2022 | 3,389.29% |
| Dec 31, 2021 | -63.87% |
| Sep 30, 2021 | 11.67% |